Flavia Jacobs

Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions

Riccardo Gerosa, Rita De Sanctis, Flavia Jacobs et al. · Critical Reviews in Oncology/Hematology · 2024 · 60 citations · Full text

Cdk Inhibitors, Cyclin-dependent Kinase 2, Metastatic Breast Cancer +10

Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients

Damiano Gentile, Andrea Sagona, Camilla De Carlo et al. · The Breast · 2023 · 32 citations · Full text

Breast Oncology, Breast Cancer Patients, Medicine +10

Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy

Corrado Tinterri, Andrea Sagona, E. Barbieri et al. · Cancers · 2023 · 27 citations · Full text

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study

L. Provenzano, M.V. Dieci, G. Curigliano et al. · Annals of Oncology · 2025 · 26 citations · Full text

Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors

Emma Zattarin, Daniele Presti, Luigi Mariani et al. · npj Breast Cancer · 2023 · 22 citations · Full text